)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Tristel
Tristel (TSTL) investor relations material
Tristel H2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2026 earnings summary19 Oct, 2026
Executive summary
FY26 turnover reached a record £51.1m, up 10% YoY; adjusted EBITDA rose 20% to £15.7m, with a 31% margin.
Results were in line with expectations, with the business described as on track to meet its FY25–FY30 financial commitments.
Financial highlights
Gross profit rose 12% to £41.9m; gross margin increased to 82% from 81%, supported by completed in-house wipe manufacturing.
Adjusted PBT increased 15% to £11.7m; reported PBT rose 30% to £11.0m and profit after tax increased 20% to £8.0m.
Adjusted EPS was 18.19p, up 6%; reported basic EPS was 16.68p, up 20%.
Revenue growth comprised £4.3m from volume and £0.3m from price; 94% of the increase came from volume.
Outlook and guidance
FY25–FY30 commitments: double-digit annual revenue growth, EBITDA margin of at least 25% annually excluding share-based payments, and progressive YoY dividend growth.
Priorities include accelerating US investment, increasing penetration in current markets, assessing geographic expansion and commercialising Unifoam and 3T Pro.
Reaching internal penetration benchmarks across current markets represents ~£60m of additional medical-device disinfection revenue potential.
Unifoam Phase 1 market launch is planned for January 2027, following trials requested by 14 NHS Trusts after the September 2026 soft launch.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tristel
- Revenue and profit growth exceeded expectations, supporting continued global expansion.TSTL
Trading update - Record revenue and profit growth, led by US expansion and strong cash generation.TSTLH1 2026
- Double-digit growth, record sales, and US expansion drive a strong long-term outlook.TSTLH2 2025
- Double-digit growth outlook driven by global expansion, digital innovation, and high-margin niches.TSTLCMD 2025
- Revenue and profit growth exceeded 10%, with robust demand and a strong cash position.TSTLH2 2025 TU
- Record financial results, strong cash flow, and North American expansion drive growth.TSTLH2 2024
- Revenue and profit exceeded expectations, driven by robust global demand and US expansion.TSTLTrading Update
- 8% revenue growth, 19% profit rise, and global expansion drive a strong outlook.TSTLH1 2025
Next Tristel earnings date
H1 20271 Mar, 2027
Tristel
Next Tristel earnings date
H1 20271 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Tristel plc is a United Kingdom-based company recognized for its specialization in manufacturing infection prevention products. The core of Tristel's business revolves around its proprietary chlorine dioxide chemistry. This innovative chemistry is deployed in two main product lines: the Tristel brand for the decontamination of medical devices and the Cache brand for the sporicidal disinfection of environmental surfaces. The company's offerings are crucial for infection control within hospital settings, encompassing a range of applications such as airway management, cardiology, ear, nose and throat, ophthalmology, endoscopy, surfaces, ultrasound, urology, hand hygiene, and women's health. The company is headquartered in Snailwell, United Kingdom, and its shares are listed on the London Stock Exchange.